School of Biology and the Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
School of Molecular and Cellular Biology and the Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
Structure. 2022 Mar 3;30(3):396-407.e3. doi: 10.1016/j.str.2021.10.010. Epub 2021 Nov 12.
B cell lymphoma 6 (BCL6) is a transcriptional repressor that is deregulated in diffuse large B cell lymphoma, and the peptide aptamer, Apt48, inhibits BCL6 by an unknown mechanism. We report the crystal structure of BCL6 in complex with an Apt48 peptide, and show that Apt48 binds to a therapeutically uncharacterized region at the bottom of the BCL6 BTB domain. We show that the corepressor binding site of the BTB domain may be divided conceptually into two low-affinity, peptide-binding regions. An upper region, the lateral groove, binds peptides in robust three-dimensional conformations, whereas a lower binding site is permissive to less-specific interactions. We show that, even with little sequence specificity, the interactions of the lower region are required for the high-affinity binding of the SMRT corepressor and other peptides to the BTB domain. This has relevance for the design of new BCL6 inhibitors and for understanding the evolution of corepressor interactions with the BTB domain.
B 细胞淋巴瘤因子 6(BCL6)是一种转录抑制剂,在弥漫性大 B 细胞淋巴瘤中被失调,肽适体 Apt48 通过未知机制抑制 BCL6。我们报告了 BCL6 与 Apt48 肽复合物的晶体结构,并显示 Apt48 结合到 BCL6 BTB 结构域底部的一个治疗上未表征的区域。我们表明,BTB 结构域的共抑制因子结合位点在概念上可以分为两个低亲和力的肽结合区域。上部区域,即侧槽,结合具有强三维构象的肽,而下部结合位点允许更不特异的相互作用。我们表明,即使序列特异性较低,下部区域的相互作用对于 SMRT 共抑制因子和其他肽与 BTB 结构域的高亲和力结合也是必需的。这对于设计新的 BCL6 抑制剂以及理解共抑制因子与 BTB 结构域相互作用的进化具有重要意义。